Understanding iDose® TR: A Breakthrough in Glaucoma Treatment thumbnail

Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

Published Nov 26, 24
1 min read


iDose® TR represents a revolutionary advancement in the treatment of glaucoma, delivering a consistent and reliable option for managing intraocular pressure (IOP). Unlike traditional eye drops that need to be applied every day, iDose® TR is a small, implantable device designed to deliver a controlled dispensation of treatment directly into the eye over an prolonged period. This cutting-edge approach reduces the burden of constant dosing, dramatically boosting patient adherence and overall treatment outcomes.

At Eye Center South, we are honored to introduce iDose® TR as part of our all-encompassing glaucoma care. The device is implanted during a simple and low-risk procedure, focused on your comfort and ease. Once in place, it ensures a steady release of glaucoma medication, keeping IOP levels consistent and safeguarding your eyesight. Patients who find challenges in the challenges of daily eye drop regimens can benefit greatly from this next-generation treatment.



Visit for more info At Eye Center South